Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries

The private for-profit sector is an important source of treatment for malaria. However, private patients face high prices for the recommended treatment for uncomplicated malaria, artemisinin combination therapies (ACTs), which makes them more likely to receive cheaper, less effective non-artemisinin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Health Policy Plan
Autors principals: Palafox, Benjamin, Patouillard, Edith, Tougher, Sarah, Goodman, Catherine, Hanson, Kara, Kleinschmidt, Immo, Torres Rueda, Sergio, Kiefer, Sabine, O’Connell, Kate, Zinsou, Cyprien, Phok, Sochea, Akulayi, Louis, Arogundade, Ekundayo, Buyungo, Peter, Mpasela, Felton, Poyer, Stephen, Chavasse, Desmond
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4748126/
https://ncbi.nlm.nih.gov/pubmed/25944705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/heapol/czv031
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars